Bicara Therapeutics, Inc. (BCAX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$23.17-0.73%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · BCAX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|---|
| Operating Expenses & Income | |||||
| R&D Expenses | — | — | 63.6 | 30.6 | — |
| Operating Income | (202.0) | (155.6) | (82.4) | (39.9) | — |
| Earnings from Continuing Operations | |||||
| Interest & Investment Income | 16.8 | 17.9 | 14.6 | 1.3 | — |
| Other Non-Operating Income / Expenses | 16.8 | 17.9 | 14.6 | (12.1) | — |
| Asset Writedown | — | — | — | 0.0 | — |
| EBT, Incl. Unusual Items | (185.2) | (137.7) | (67.8) | (52.0) | — |
| Income Tax Expense | 0.2 | 0.2 | 0.2 | 0.0 | — |
| Net Income | |||||
| Net Income | (185.4) | (138.0) | (68.0) | (52.0) | — |
| Per Share | |||||
| Basic EPS | (2.73) | (2.52) | (4.05) | (89.61) | — |
| Diluted EPS | (2.73) | (2.52) | (4.05) | (89.61) | — |
| Basic Weighted Avg Shares | 67.9 | 54,676.9 | 16,805.5 | 580.1 | — |
| Diluted Weighted Avg Shares | 67.9 | 54,676.9 | 16,805.5 | 580.1 | — |
| Supplemental | |||||
| EBIT | (202.0) | (155.6) | (82.4) | (39.9) | — |
| Effective Tax Rate | -0.1% | — | — | -0.0% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.